Daiichi Sankyo reports positive results for tivantinib
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2012
Singapore: Biotech company ArQule and Japan-based Daiichi Sankyo have achieved positive results from a randomized, place...Read more
Eisai expands its anti-obesity drug market
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2013
Singapore: Global pharmaceutical firm, Eisai has expanded the marketing and supply agreement between its U.S. subsidiary...Read more
Merck gets cancer drug license from Symphogen
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: Symphogen signed an exclusive worldwide license agreement with Merck in Germany for Sym004, an investigationa...Read more
Kinex receives funds from Hong Kong govt ITC
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: US-based Kinex Pharmaceuticals's application for the Small Entrepreneur Research Assistance Programme has bee...Read more
Singapore's first flu vaccine clears phase I trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) a...Read more
Exjade gets FDA nod for iron overload treatment
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 24 Jan, 2013
Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years...Read more
Customized treatments to dominate oncology therapy
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 11 Jul, 2012
Singapore: Cancer treatments are becoming increasingly personalized, as regulators are approving therapeutics offering s...Read more
GSK, Theravance seek EU nod for COPD drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2013
Singapore: GlaxoSmithKline (GSK) and Theravance submitted a regulatory application in the European Union for the investi...Read more
Role of oxidative stress in autism disorder found
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013
Singapore: In an effort to explore biological influences on the varying appearance of autism spectrum disorder (ASD), Dr...Read more
CSL Behring progresses on novel drug for Hemophilia A
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2013
‎Singapore: Australia-based CSL Behring achieved improved pharmacokinetic results for its novel investigational re...Read more
Sanofi begins biopharmaceutical plant construction
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to...Read more
Allied abdominal hernia study shows +ve results
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2013
Singapore: Allied Healthcare has achieved positive results in the study of Adapt-treated tissue as a bioprosthetic subst...Read more
Biotron's HIV drug candidate reverses impaired immune system
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2014
Singapore: Australia based Biotron's HIV drug candidate BIT225 has demonstrated its ability to reverse HIV-induced impai...Read more
GRPE elements to help cure HIV via gene therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Apr, 2013
Singapore: A research team from Case Western Reserve University School of Medicine has discovered an approach that could...Read more
Charles River manages 2.9% growth in Q2, 2013
Drug Discovery | Company results | By BioSpectrum Bureau | 9 Comment | 01 Aug, 2013
Singapore: Drug development company Charles River Laboratories has marked net sales of $292.9 million in the second quar...Read more
Coherus starts ph3 trial of rheumatoid arthritis biosimilar drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0...Read more
Study: Novartis' Afinitor hinders kidney tumor
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2013
Singapore: A phase III study conducted at the Cincinnati Children's Hospital Medical Center, US, has revealed that pati...Read more
Concert Pharma, Celgene enter in $300 mn merger
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deut...Read more